<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.37072.023</object-id><label>Table 2.</label><caption><title>Organization of CFU&#8217;s quantification for growth assays.</title></caption><table frame="hsides" rules="groups"><thead><tr><th><italic>E. coli&#160;+&#160;H. alvei</italic> JB232</th><th>LB (<italic>E. coli&#160;+&#160;H. alvei</italic> JB232 CFUs) LB-kanamycin (50 &#181;g/ml) (<italic>E. coli</italic> CFUs)</th></tr></thead><tbody><tr><td><italic>E. coli&#160;+&#160;G. candidum</italic></td><td>LB-kanamycin:cycloheximide (50 &#181;g/ml and 10 &#181;g/ml) (<italic>E. coli</italic> CFUs) LB-chloramphenicol (<italic>G. candidum</italic> CFU&#8217;s)</td></tr><tr><td><italic>E. coli&#160;+&#160;P. camemberti</italic></td><td>LB-kanamycin:cyclohexamide (50 &#181;g/ml and 10 &#181;g/ml) (<italic>E. coli</italic> CFUs) LB-chloramphenicol (50 &#181;g/ml)(<italic>P. camemberti</italic> CFU&#8217;s)</td></tr><tr><td><italic>E. coli</italic>&#160;+&#160;Community</td><td>LB-cyclohexamide (10 &#181;g /mL) (<italic>E. coli</italic> and <italic>H. alvei</italic> JB232 CFU&#8217;s), LB-kanamycin:cyclohexamide (50 &#181;g/ml and 10 &#181;g/ml) (<italic>E. coli</italic> CFU&#8217;s) and LB-chloramphenicol (50 &#181;g/ml) (<italic>G. candidum</italic> and <italic>P. camemberti</italic> CFU&#8217;s)</td></tr></tbody></table></table-wrap>